Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Retinoblastoma × Topotecan × Clear all

Phase

Status

Completed 4 Recruiting 3 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Prostatic Neoplasms 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Glioma 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Advanced Solid Tumors 1

Interventions

Vincristine 2 Filgrastim 2 Carboplatin 2 Topotecan 1 Thiotepa 1 Temozolomide 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Leucovorin 1 Etoposide 1 Cyclophosphamide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00980551 2017-03-03

RELRB1

Children's Hospital Medical Center, Cincinnati

Phase NA Withdrawn

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡